Opinions
Charles Bobrinskoy
IMS Health Inc
RX-N
TOP PICK
Aug 13, 2009
Relatively small company but the leading dominant provider of data to the pharmaceutical industry. When a drug company wants information about how its drugs are selling, what doctors are prescribing those drugs they go to this company. Great value at about 9X earnings.
$13.230
Stock price when the opinion was issued
other services
It's the ideal tool to help you make quicker, more informed decisions for
managing and tracking your investments.
You might be interested:
TOP PICK
It is a proprietary global database for things like where drugs are being sold, who's prescribing, for what conditions, etc. About 8 times as large as their nearest competitor. Have has problems with their Japanese information which is now being corrected and they are coming back into profitability.
other services
Advertising